Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07823972
NA
Dapagliflozin and Right Heart Recovery After ASD Device Closure
Sponsor: Assiut University
View on ClinicalTrials.gov
Summary
The aim of this study is to evaluate the clinical and echocardiographic influence of dapagliflozin on right ventricular reverse remodeling in adult patients following successful transcatheter Atrial Septal Defect (ASD) device closure.
Official title: Impact of Dapagliflozin Therapy on Right Ventricular Remodeling Following Transcatheter Atrial Septal Defect Closure in Adults: Randomized Clinical Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2026-11-01
Completion Date
2029-01-30
Last Updated
2026-09-17
Healthy Volunteers
Yes
Conditions
Interventions
DEVICE
trans catheter device closure
randomized clinical trila
Locations (1)
Assiut university
Asyut, Egypt